Current Report — Form 8-K Filing Table of Contents
Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 29K
2: EX-99.1 Miscellaneous Exhibit HTML 16K
9: R1 Document and Entity Information HTML 46K
11: XML IDEA XML File -- Filing Summary XML 12K
8: XML XBRL Instance -- hae-20210419_htm XML 21K
10: EXCEL IDEA Workbook of Financial Reports XLSX 6K
4: EX-101.CAL XBRL Calculations -- hae-20210419_cal XML 7K
5: EX-101.DEF XBRL Definitions -- hae-20210419_def XML 9K
6: EX-101.LAB XBRL Labels -- hae-20210419_lab XML 67K
7: EX-101.PRE XBRL Presentations -- hae-20210419_pre XML 33K
3: EX-101.SCH XBRL Schema -- hae-20210419 XSD 11K
12: JSON XBRL Instance as JSON Data -- MetaLinks 12± 18K
13: ZIP XBRL Zipped Folder -- 0000313143-21-000012-xbrl Zip 17K
(Address of principal executive offices, including zip code)
Registrant’s
telephone number, including area code: i781-i848-7100
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
stock, $.01 par value per share
iHAE
iNew York Stock Exchange
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company
i☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On April 19, 2021, Haemonetics Corporation (the “Company”) issued a press
release announcing that CSL Plasma, Ltd. (“CSL”) has informed the Company of its intent not to renew its supply agreement with the Company for the use of PCS2® Plasma Collection System devices and the purchase of disposable plasmapheresis kits (the “Supply Agreement”) following the expiration of the current term of the Supply Agreement in June 2022.
This Current Report on Form 8-K contains forward-looking statements, including, but not limited to, statements regarding (i) CSL’s notice of intent not to renew the Supply Agreement; (ii) the anticipated consequences of non-renewal of the Supply Agreement, including the anticipated impairment charge and expenses to be incurred, and the ability of the Company to respond to these changes; (iii) future positive cash flow and the pursuit of strategies to deliver shareholder value; (iv) the potential of the Company’s plasma
products, including NexSys PCS® and Persona®; (v) the anticipated long-term growth in the U.S. source plasma collections market, and (vi) the assumptions underlying or relating to any statement described in points (i) to (v) above. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of risks and uncertainties, which include, without limitation, the risk that CSL may determine to renew the Supply Agreement for additional periods. Investors should consult the Company’s filings with the U.S. Securities and Exchange Commission (including the Company’s reports on Forms 10-K, 10-Q and 8-K) for information about
additional risks and uncertainties that could cause the Company’s actual results to differ materially from these forward-looking statements. The Company undertakes no duty or obligation to update any forward-looking statements contained in this Current Report on Form 8-K as a result of new information, future events or changes in its expectations.
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
